Literature DB >> 15201242

Relation between C reactive protein concentrations and coronary microvascular endothelial function.

H Teragawa1, Y Fukuda, K Matsuda, K Ueda, Y Higashi, T Oshima, M Yoshizumi, K Chayama.   

Abstract

OBJECTIVE: To determine how C reactive protein (CRP), a sensitive marker of inflammation, is related to coronary endothelial function.
DESIGN: Changes in quantitative coronary angiographic findings and Doppler flow velocity measurements in response to locally infused acetylcholine were assessed.
SETTING: Tertiary cardiology centre. PATIENTS: 46 patients with angiographically normal coronary arteries were divided into groups with normal (< or = 3 mg/l) or increased (> 3 mg/l) CRP concentrations.
INTERVENTIONS: Acetylcholine (3 and 30 microg/min) was infused into the left coronary ostium for two minutes. MAIN OUTCOME MEASURES: Percentage change in diameter of epicardial coronary arteries and coronary blood flow (CBF) in response to acetylcholine; and correlations between these parameters and serum CRP concentrations.
RESULTS: 15 patients had increased CRP concentrations. The change in coronary artery diameter induced by acetylcholine infusion was similar between the groups but the increase in CBF induced by acetylcholine was smaller in patients with increased CRP concentrations (54.9% v 139.4% with acetylcholine 30 microg/min, p = 0.0030). Multivariate analysis identified increased CRP concentration as independently associated with attenuated CBF response to acetylcholine at 30 microg/min (p = 0.0078, R2 = 0.434).
CONCLUSIONS: These findings suggest that inflammation appears to be associated with impaired coronary endothelial function in resistance but not conduit vessels. The data suggest a close relation between chronic vascular inflammation and endothelial dysfunction in atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15201242      PMCID: PMC1768328          DOI: 10.1136/hrt.2003.022269

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  33 in total

1.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Authors:  Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

Review 2.  Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

Authors:  Paul M Ridker
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

3.  Nitric oxide activity in the atherosclerotic human coronary circulation.

Authors:  A A Quyyumi; N Dakak; D Mulcahy; N P Andrews; S Husain; J A Panza; R O Cannon
Journal:  J Am Coll Cardiol       Date:  1997-02       Impact factor: 24.094

4.  Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia.

Authors:  Y Fukuda; H Teragawa; K Matsuda; T Yamagata; H Matsuura; K Chayama
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

5.  Short-term triglyceride lowering with fenofibrate improves vasodilator function in subjects with hypertriglyceridemia.

Authors:  Warren H Capell; Christopher A DeSouza; Paul Poirier; Melanie L Bell; Brian L Stauffer; Kathleen M Weil; Teri L Hernandez; Robert H Eckel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-01       Impact factor: 8.311

6.  Prevention of inflammation-induced endothelial dysfunction: a novel vasculo-protective action of aspirin.

Authors:  Rajesh K Kharbanda; Benjamin Walton; Meredith Allen; Nigel Klein; Aroon D Hingorani; Raymond J MacAllister; Patrick Vallance
Journal:  Circulation       Date:  2002-06-04       Impact factor: 29.690

7.  Nitric oxide production by coronary conductance and resistance vessels in hypercholesterolemia patients.

Authors:  N Shiode; K Nakayama; N Morishima; T Yamagata; H Matsuura; G Kajiyama
Journal:  Am Heart J       Date:  1996-06       Impact factor: 4.749

Review 8.  Inflammation in atherosclerosis.

Authors:  Peter Libby
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

9.  A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis.

Authors:  Subodh Verma; Chao-Hung Wang; Shu-Hong Li; Aaron S Dumont; Paul W M Fedak; Mitesh V Badiwala; Bikramjit Dhillon; Richard D Weisel; Ren-Ke Li; Donald A G Mickle; Duncan J Stewart
Journal:  Circulation       Date:  2002-08-20       Impact factor: 29.690

10.  Endothelial dysfunction and inflammation in asymptomatic proteinuria.

Authors:  Karen E Paisley; Martin Beaman; John E Tooke; Vidya Mohamed-Ali; Gordon D O Lowe; Angela C Shore
Journal:  Kidney Int       Date:  2003-02       Impact factor: 10.612

View more
  17 in total

1.  C reactive protein and microvascular function.

Authors:  F Tomai
Journal:  Heart       Date:  2004-07       Impact factor: 5.994

2.  Invasive coronary vasoreactivity testing to diagnose microvascular dysfunction in women.

Authors:  Alison L Bailey; Susan S Smyth
Journal:  JACC Cardiovasc Interv       Date:  2012-06       Impact factor: 11.195

Review 3.  Effects of systemic inflammation on endothelium-dependent vasodilation.

Authors:  Alex L Huang; Joseph A Vita
Journal:  Trends Cardiovasc Med       Date:  2006-01       Impact factor: 6.677

Review 4.  Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade.

Authors:  C Noel Bairey Merz; Carl J Pepine; Mary Norine Walsh; Jerome L Fleg
Journal:  Circulation       Date:  2017-03-14       Impact factor: 29.690

5.  Impaired coronary microvascular endothelial function in men with metabolic syndrome.

Authors:  Hiroki Teragawa; Naoya Mitsuba; Kenji Nishioka; Kentaro Ueda; Shingo Kono; Yukihito Higashi; Kazuaki Chayama; Yasuki Kihara
Journal:  World J Cardiol       Date:  2010-07-26

Review 6.  Anti-inflammatory strategies in hypertension: focus on COX-1 and COX-2.

Authors:  Matthias Hermann; Frank Enseleit; Frank T Ruschitzka
Journal:  Curr Hypertens Rep       Date:  2005-02       Impact factor: 5.369

7.  Acute phase proteins activation in subjects with coronary atherosclerosis and micro-vessel coronary circulation impairment.

Authors:  Natale Daniele Brunetti; Roberto Padalino; Luisa De Gennaro; Andrea Cuculo; Luigi Ziccardi; Pier Luigi Pellegrino; Matteo Di Biase
Journal:  J Thromb Thrombolysis       Date:  2008-08-09       Impact factor: 2.300

8.  Relationship between hs-CRP and cardiac efficiency in chronic alcoholics.

Authors:  R Latha; K Chandrakala Shenoy
Journal:  Indian J Clin Biochem       Date:  2008-10-01

9.  Evaluation of coronary microvascular function in patients with vasospastic angina.

Authors:  Hiroki Teragawa; Naoya Mitsuba; Ken Ishibashi; Kenji Nishioka; Satoshi Kurisu; Yasuki Kihara
Journal:  World J Cardiol       Date:  2013-01-26

10.  Positive influence of aspirin on coronary endothelial function: Importance of the dose.

Authors:  Hiroki Teragawa; Naoya Mitsuba; Ken Ishibashi; Satoshi Kurisu; Yasuki Kihara
Journal:  World J Cardiol       Date:  2013-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.